Table 3.

Median percentage availability of selected diabetes medicines in each country and mean percentage availability of innovator brand and lowest priced generic in each country

Medicines		Afghanistan	Armenia	Bangladesh	China	Egypt	Georgia	India	Jordan	Nepal	Oman	Pakistan	Qatar	Russia	Saudi Arabia	Sri Lanka	Tanzania	United Arab Emirates	Total mean percentage availability
Metformin 500 mg	IB	100	100	0	33	33	100	0	100	0	100	100	100	100	100	67	33	100	69
LPG	100	100	100	100	33	100	66	66	100	100	100	100	100	100	50	100	100	100	89
Metformin 850 mg XR	IB	67	0	0	0	0	33	0	0	0	33	0	0	100	50	33	0	0	19
LPG	33	33	0	100	33	100	33	67	0	100	66	100	33	100	0	33	100	0	53
Gliclazide 80 mg	IB	0	0	0	67	33	0	0	0	0	0	100	33	0	50	67	0	0	21
LPG	0	0	20	100	67	100	0	67	0	100	100	100	33	0	0	100	0	0	46
Insulin 100 IU/ml	IB	33	0	0	67	0	0	100	100	0	0	100	100	33	50	100	100	67	50
LPG	0	0	40	0	33	0	0	50	100	0	0	100	0	0	25	33	0	0	26
Total mean percentage availability		42	33	38	42	46	29	44	50	38	50	88	50	54	41	63	38	50
Total mean percentage availability of IB		50	25	0	42	17	33	25	50	0	33	75	58	58	63	67	25	50
Total mean percentage availability of LPG		33	40	75	42	75	25	63	50	75	67	100	42	50	19	58	50	50

≤30, very low; 30–49, low; 50–80, fairly high; ≥80, high.